Heterocyclic compounds and methods of use

Details for Australian Patent Application No. 2004223827 (hide)

Owner Amgen Inc

Inventors Patel, Vinod F.; Dipietro, Lucian V.; Van Der Plas, Simon; Habgood, Gregory J.; Elbaum, Daniel; Kim, Joseph L.; Potashman, Michele; Askew, Jr. Benny C.; Harmange, Jean-Christophe; Germain, Julie

Agent Shelston IP

Pub. Number AU-B-2004223827

PCT Pub. Number WO2004/085425

Priority 60/456,691 21.03.03 US; 10/804,915 19.03.04 US

Filing date 22 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 6 March 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/085425 Priority application(s): WO2004/085425

24 November 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Heterocyclic compounds and methods of use 2004224457 BP Corporation North America Inc. The nature of the amendment is: Amend the name of the applicant from BB Corporation North America Inc. to BP Corporation North America Inc.

6 March 2008 Application Accepted

  Published as AU-B-2004223827

3 July 2008 Standard Patent Sealed

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004223828-Cyclic protein tyrosine kinase inhibitors

2004223820-Polytrimethylene ether diol containing coating compositions